510(k) K231861

EndoflipTM 300 System by Covidien, LLC — Product Code FFX

K231861 is an FDA 510(k) premarket notification submitted by Covidien, LLC for the device "EndoflipTM 300 System". The FDA issued a decision of Substantially Equivalent on July 21, 2023. The device falls under product code FFX (System, Gastrointestinal Motility (Electrical)), a Class II device regulated under 21 CFR 876.1725. Covidien, LLC has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 21, 2023
Date Received
June 23, 2023
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Gastrointestinal Motility (Electrical)
Device Class
Class II
Regulation Number
876.1725
Review Panel
GU
Submission Type